
    
      This study will be a multicenter, randomized, controlled trial conducted from November, 2018
      to November, 2019 that includes 108 participants who have simple obesity and meet the
      eligibility criteria. The participants will be randomly divided into 3 treatment groups: heat
      application group, medicated plaster group, or herb-partitioned moxibustion group. Each
      treatment will last 4 weeks. The primary outcomes will be the clinical effectiveness.The
      secondary outcome measures include participants'obesity-related indicators, the IWQOL-Lite
      scale, and the syndrome score of Traditional Chinese Medicine. Adverse events will be
      recorded during the intervention period.
    
  